SCHEMBL25856128

SCHEMBL25856128

CCC1CCN(C2CN(CC3CCN(C)CC3)C2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.42
CACNA2D1 P54289 1/20 0.33
CACNA1B Q00975 1/20 0.33
CACNB1 Q02641 1/20 0.33
CACNA1C Q13936 1/20 0.33
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
GRIN2B Q13224 1/20 0.31
GNAI3 P08754 1/20 0.31
GNAO1 P09471 1/20 0.31
GNAI1 P63096 1/20 0.31
ACHE P22303 1/20 0.31
CHRM5 P08912 1/20 0.31
ADRA2C P18825 1/20 0.31
SCN1A P35498 1/20 0.30
SCN4A P35499 1/20 0.30
SCN7A Q01118 1/20 0.30
KCNH2 Q12809 1/20 0.30
SCN5A Q14524 1/20 0.30
SCN9A Q15858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25571690 0.87 NCF1 (0.47) NCF1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL24481341 0.86 ACHE (0.46) NCF1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL24319799 0.83 NCF1 (0.45) NCF1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL24480861 0.82 NCF1 (0.45) NCF1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL25027121 0.81 POLB (0.34) NCF1MEN1KMT2AGNAI3GNAO1
SCHEMBL11919059 0.81 NCF1 (0.46) NCF1MEN1KMT2AGRIN2BGNAI3
SCHEMBL22703786 0.81 NCF1 (0.37) NCF1MEN1KMT2A
SCHEMBL24319182 0.81 NCF1 (0.46) NCF1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL23384365 0.81 NCF1 (0.46) NCF1MEN1KMT2AGRIN2BGNAI3
SCHEMBL22703783 0.80 NCF1 (0.40) NCF1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO disclosed